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Abstract: Propolis and its compounds have been the subject of many studies due to their antimicrobial and anti-
inflammatory activity; however, it is now known that they also possess antitumor properties. This review aims to
summarize the results of studies on the mechanism of activity of propolis and its active compounds such as
CAPE and chrysin in the apoptotic process, and their influence on the proliferation of cancer cells. Our review
shows that propolis and its presented compounds induce apoptosis pathways in cancer cells. The antiprolifera-
tive effects of propolis, CAPE or chrysin in cancer cells are the result of the suppression of complexes of cyclins,
as well as cell cycle arrest. The results of in vitro and in vivo studies suggest that propolis, CAPE and chrysin may
inhibit tumor cell progression and may be useful as potential chemotherapeutic or chemopreventive anticancer
drugs. (Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 1, 25–37)
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Introduction
Propolis, also called bee putty or bee glue, is a substance
produced by bees from the resin collected from trees
and shrubs, which combines with beeswax and secre-
tions from the bee’s salivary glands rich in enzymes. It
can be yellow, brown or almost black, depending on the
plants from which the resinous substance is collected.
The smell of propolis is intense and aromatic [1].
The use of propolis by humans has a long history.
The Egyptians used it for embalming the body be-
cause it was the perfect plastic material that further
protected the mummy from bacteria, fungi and virus-
es [2]. Propolis has been the subject of many studies
due to its antibacterial, antifungal [3–11], antiviral [12–
–14] and hepatoprotective activity. Water- or alcohol-
soluble propolis and its many compounds have been
used in the treatment of inflammation, for immuno-
stimulation [11], and as an anticancer agent. The
above-mentioned properties of propolis make it an
unusual material of natural origin, characterized by
a specific composition.
Chemical composition of propolis
The diversity of propolis’s chemical composition is
presented in Table 1. In general, the main compo-
nents of propolis are fatty, aliphatic and aromatic
acids, flavonoids, alcohols, terpenes, sugars and es-
ters. Several studies have confirmed the differences
in percentages of individual components of propolis,
depending on the origin of the plants from which the
resin is collected [15, 16] and the species of bees [17].
In vitro studies
The influence of propolis and its compounds on the
apoptotic process in cancer cells
The positive effect of anticancer therapy is seen in
the ability to initiate apoptosis in cancer cells [26].
Apoptosis is a genetically regulated cell death. In gen-
eral, there are two main pathways of apoptosis.
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Table 1. Chemical composition of propolis based on: [18–25]
Compounds (percentage of content)
Fatty and aliphatic acids (24–26%) Flavonoids (18–20%) Microelements (0.5–2.0%)
Butanedioic acid (Succinic acid) Astaxanthin Aluminum (Al)
Propanoic acid (Propionic acid) Apigenin Copper (Cu)
Decanoic acid (Capric acid) Chrysin Magnesium (Mg)
Undecanoic acid Tectochrysin Zinc (Zn)
Malic acid Pinobanksin Silicon (Si)
D-Arabinoic acid Squalene Iron (Fe)
Tartaric acid Pinostrobin chalcone Manganese (Mn)
Gluconic acid Pinocembrin Tin (Sn)
a-D-Glucopyranuronic acid Genkwanin Nickel (Ni)
Octadecanoic acid (Stearic acid) Galangin Chrome (Cr)
Hexadecanoic acid Pilloin
b-D-Glucopyranuronic acid Acacetin
9,12-Octadecadienoic acid Kaemferide
Tetradecanoic acid Rhamnocitrin
Pentanedioic acid 7,4’-dimethoxyflavone
Glutamic acid 5-hydroxy-4’7-dimethoxyflavone
2,3,4-trihydroxy butyric acid 5,7-dihydroxy-3,4’dihydroxyflavone
Phosphoric acid 3,5-dihydroxy-7,4’-dimethoxyflavone
Isoferulic acid Sugars (15–18%) Others (21–27%)
Sorbopyranose Cyclohexanone
D-Erythrotetrofuranose 3-methyl,antitricyclo undec-3-en 10-one
D-Altrose Cyclohexane
D-Glucose Cyclopentene
Arabinopyranose 5-n-propyl-1,3 dihydroxybenzene
d-Arabinose Butane
a-D-Galactopyranose 2(3H)-Furanone
Maltose L-Proline
a-D-Glucopyranoside 2-Furanacetaldehyde
D-Fructose 2,5-is-3-phenyl-7-pyrazolopyrimidine
Aromatic acids (5–10%) Esters (2–6%) Cliogoinol methyl derivative
Benzoic acid Caffeic acid phenethyl ester Fluphenazine
Caffeic acid 4,3-Acetyloxycaffeate 4,8-Propanoborepinoxadiborole
Ferulic acid Cinnamic acid, 1,3,8-Trihydroxy-6-methylanthraquinone
Cinnamic acid 3,4 dimethoxy-trimethylsilyl ester 1-5-oxo-4,4-diphenyl-2-imidazolin-2-yl guanidine
3-Methoxy-4-cinnamate 3,1,2-Azaazoniaboratine/Piperonal
Cinnamic acid 4 methoxy 3 TMS ester 3-Cyclohexene
2-propenoic acid methyl ester 1H-Indole
Alcohol and terpens (2–3.3%) Vitamins (2–4%) 1H-Indole-3-one
Glycerol A, B1, B2, E, C, PP 2-Furanacetaldehyde
Erythritol Guanidine
a-Cedrol 2(3H)Furanone
Xylitol 1,3,8-trihydroxy-6-meyhylanthraquinone
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The first is induced by an external signal (extrin-
sic) stimulated by receptors of tumor necrosis factor
(TNF): Fas (TNF receptor superfamily, member 6),
TRAIL-R1 and R-2 (TNF-related apoptosis-induc-
ing ligand-R1 and R2).
The second pathway (intrinsic) is mediated by mi-
tochondria and pro-apoptotic proteins including cy-
tochrome c [27]. Apoptosis induction is one of the
mechanisms proposed for the therapeutic effects of
propolis [28, 29]. The mechanism of apoptosis induced
by propolis seems dependent on the kind of com-
pounds and the concentration of the propolis extract.
Recent studies suggest that the astaxanthin and fla-
vonoids in propolis can protect SH-SY5Y cells from
beta-amyloid (A beta) (25-35) induced apoptotic
death [23].
The effect of propolis on the apoptotic process
in cancer cells
In vitro studies show different sensitivities
of tumor cells to extracts of propolis in the context of
apoptosis.
The antitumor effect of water-soluble derivatives
of propolis (WSDP) from Croatia and Brazil on
mammary carcinoma cells (MCA), human epithe-
lial carcinoma cell line (HeLa), and Chinese ham-
ster lung fibroblast cells (V79) have been studied by
Orsolic and Basic [30]. Their study showed that the
percentage of apoptotic MCA cells increased from
20% (in controls) to 24% and 26% after exposure
to 50 μg/ml of Brazilian and Croatian propolis, re-
spectively. The percentage of apoptotic HeLa cells
(2% in controls) was 10% for Croatian propolis and
9.5% for Brazilian propolis. However, the percent-
age of apoptotic V79 cells treated with both Brazil-
ian and Croatian propolis was smaller than in non-
treated cells. These results indicate different degrees
of sensitivity to propolis among cancer cells and
normal fibroblasts.
Similarly, a study by Orsolic et al. [31] showed
a slight increase in the percentage of apoptotic MCa
cells from 0.56% after 3 h to 6.02% after 15 h of incu-
bation with tested WSDP (50 μg/ml) and, within the
same two periods of time, a significant increase in the
level of cells necrosis was observed. The authors sug-
gested that WSDP induced low apoptotic effect on
MCa cells may be the result of complexity, i.e. the
large number of components might have an antago-
nistic effect on one another.
A more significant (2.1–40.1%) proapoptotic ef-
fect of propolis (in the concentration-dependent man-
ner: 0.015–0.5 μl/ml) has been observed in human
histiocytic lymphoma cells (U937) [29]. In the same
concentration range, propolis also inhibited cell
growth in the studied cells.
Antitumor activity of ethanol extract of propolis
(EEP), which is one of the richest sources of phenol-
ic acids and flavonoids from Turkey, on the percent-
age of TUNEL positive human breast cancer cell line
MCF-7, shows that apoptosis induction is strongly de-
pendent on the concentration and dilutions of EEP. In
the antitumor activity, dilutions of EEP 0.125 and 0.063
mg/ml were more effective (17.5–100%) than dilutions
of EEP 0.25 and 0.5 mg/ml (5.11–18.97%) [32].
These observations are of great interest, and many
researchers have tried to specify the mechanism of
the proapoptotic effect of propolis. Aso et al. [29] were
the first to show that propolis induces apoptosis
through activating caspase-dependent pathway. They
investigated the effect of caspase inhibitor Z-Asp-
-CH2-DCB on the DNA fragmentation stimulated by
propolis (0.1 μl/ml). Complete prevention of DNA
fragmentation of U937 cells and J447.1, P388, HL-60
and Jurkat leukemia cell lines suggests that such an
effect is not cell-specific [29].
The study by Motomura et al. [33] indicates that meth-
anol extracts of propolis (300 μg/ml and 500 μg/ml)
increase apoptosis in U937 cells due to the activation
of caspase-3 and down-regulation of Bcl-2 protein.
The overactivity of caspase-6 induced by EEP is stron-
ger than the induced activity of caspase-8 and -9 in
MCF-7 cells, which confirms the involvement of in-
trinsic caspase pathway of apoptosis and the antitu-
mor activity of propolis [32]. Additionally, the above
observation is in line with results of a study in which
propolis induced apoptosis through the release of cyto-
chrome c from mitochondria to the cytosol and through
activating caspase-3 in human leukemia HL-60 cells in
a concentration-dependent manner (3–50 μg/ml for cy-
tochrome c and 10–50 μg/ml for caspase-3) [34]. The
cell death induced by propolis was largely prevented by
treating HL-60 cells with 30 μM z-DEVD-fmk,
a caspase-3 inhibitor [23].
Table 1. Chemical composition of propolis based on:
[18–25] cont.
Alcohol and terpens (2–3.3%)
Germanicol
Stigmast-22-en-3-ol
Farnesol
Pentitol
Ribitol
Vanilethanediol
Bicyclohept-3-en-2-ol
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The extrinsic pathway of apoptosis was also induced
by propolis. Results obtained by Szliszka et al. [35] indi-
cate that EEP (50 μg/mL) markedly augmented tumor
necrosis factor related apoptosis inducing ligand (TRAIL)
in HeLa cell line. TRAIL, as a member of TNF super-
family, induces programmed death in cancer cells through
its interaction with the death-domain containing recep-
tor TRAIL-R1 (death receptor 4 — DR4) and/or
TRAIL-R2 (death receptor 5 — DR5) [36, 37].
The mechanism of propolis-induced apoptosis ap-
pears to be independent of the kind of cancer cells stud-
ied, but dependent on the concentration of propolis
extract. Studies available in the literature indicate that
propolis induces apoptosis through the release of cy-
tochrome c from mitochondria to the cytosol, through
the caspase cascade and TRIAL signal. All these ef-
fects of propolis are summarized in Figure 1.
Despite the results on the proapoptotic activity of
propolis, the study by Nadia et al. [38] demonstrates
the antiapoptotic effect of propolis. Induced perme-
ability transition pore (PTP) opening in the rat liver
mitochondria after exposure to ferulenol, a sesquit-
erpene prenylated coumarin derivative isolated from
the plant Ferula vesceritensis [38], was restored by
propolis and in this way the apoptotic process was
prevented. Since opposite effects of propolis on apo-
ptosis have been published, further studies are nec-
essary to understand the exact influence of propolis
on the apoptotic pathways in cancer cells.
The effect of propolis compounds on
apoptosis pathways in cancer cells
The search for active compounds of propolis led to
the extraction of CAPE and chrysin, which are be-
lieved to be mainly responsible for the antitumor ther-
apeutic activities of propolis. The cancer inhibitory
effects of CAPE and chrysin have been confirmed in
a variety of culture cell lines.
The major activity of propolis is the result of the
presence of CAPE in propolis. A particularly high
concentration of this compound was found in the New
Zealand propolis called BIO 30. Previous studies have
shown the usefulness of CAPE through its anti-in-
flammatory [39–41], immunostimulatory [31, 42], and
antitumor activity.
CAPE exhibits strong antitumor effects in oral
cancer cells: fibroblasts from oral submucous fibrosis
(OSF), neck metastasis of Gingiva carcinoma (GNM)
and tongue squamous cell carcinoma (TSCCa) [43].
Orsolic et al. [31] observed significant enhancement
of apoptosis to 31.24% in MCa cells with CAPE (5 or
10 μg/ml) after 15 h of incubation.
To understand the pathways involved in the pro-
apoptotic effect of CAPE, many studies have been
conducted. In most of them, increased activity of
caspase-3 or caspase-7 was presented in various types
of cancer cells: HL-60, CI41, U937, human ovarian
carcinoma SK-OV-3, human lung carcinoma
Figure 1. Effect of propolis on apoptosis pathways in cancer cells based on [24–29]. Bcl-2 — B cell lymphoma 2 protein;
Cyt. C — cytochrome C; Apaf-1 — apoptotic protease activating factor 1; TNF — tumor necrosis factor;
TRAIL — TNF related apoptosis-inducing ligand; TRADD — TNFR associated death domain protein
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NCI-H358, human hepatocellular carcinoma HepG2,
C6 glioma, human cervical cancer ME180, human pan-
creatic cancer PANC-1, and BxPC-3 cells [44–50]. It
appears that the beneficial effect of CAPE is not dose-
or concentration-dependent, since the increased ac-
tivity of caspase-3 was observed when CAPE was used
at a dose of 5 μg/mL, 6 μg/mL or 10 μg/ml [44] or at
different concentrations: 5 μM [45], 50 μM [46] or
10–100 μM [48]. Additionally, CAPE induced activi-
ty of other proteins involved in the pro-apoptotic pro-
cess, such as Bax or Bak, and reduced the expression
of Bcl-2 which is an inhibitor of apoptosis [44, 46, 48,
49]. Also, CAPE, similarly to propolis, releases cyto-
chrome c, which suggests that intrinsic pathways of
apoptosis are affected by CAPE [46, 50]. Moreover,
the number of apoptotic HeLa cells increased to
49.6% after treatment with 50 μg/ml CAPE and 100
ng/ml TRAIL [35]. This result indicates the extrinsic
pathway of apoptosis involved in the action of CAPE.
Other studies have demonstrated that many pro-
teins involved in the apoptotic process are affected
by CAPE. The mechanisms of inhibition of tumor
growth by CAPE are caused by the induction of the
activity of p53 [28, 45, 46, 49], p21protein [47], p38
MAPK and JNK kinase [46, 47, 49] and a result of
NF-kB inhibition [49, 50] associated with the down-
regulation of IAPs such as cIAP-1 and cIAP-2 ex-
pression [51].
CAPE induces apoptosis (Figure 2) by the activa-
tion of Bax, p53, p21 proteins, p38 MAPK, JNK, ERK
kinases, the release of cytochrome c into the cytosol,
and induction of caspase cascade activity. A study by
Szliszka et al. [35] also suggests that CAPE inhibits
NF-kB and enhances extrinsic pathway of apoptosis
in cancer cells induced by TRAIL and Fas receptor
stimulation. All these effects seem to be independent
of the type of tumor cells and the concentration or
dose of CAPE.
Chrysin (5,7-dihydroxyflavone) is another com-
ponent of propolis that shows significant biologi-
cal and pharmacological properties. It is a natural
flavonoid found in plant extracts (Passiflora caer-
ulea, Populus tremula) [52], honey and propolis.
Chrysin has antioxidant and anti-inflammatory ef-
fects [53, 54]. The anti-cancer property of chrysin
has previously been demonstrated, although the
molecular mechanisms are still not clear. This fla-
vonoid influences the apoptotic process in many
types of cell lines.
Chrysin (5, 7.5 and 10 μM) induces apoptosis in
U937 cells by the inactivation of PI3K/Akt signal path-
way as well as downregulation of NF-kB and IAP ac-
tivation, and in this way it stimulates caspase-3 which
plays a crucial role in cell death [55]. An increase in
the activity of PI3K and Akt is typically observed in
cancer cells [56]. Additionally, U937 cells treated for
12 h with chrysin (7.5 and 10 μM) released cyto-
chrome c from the mitochondria into the cytoplasm
[55]. Woo et al. [55] concluded that chrysin, as
a natural, nontoxic substance, is a potentially impor-
tant agent to be used in prevention or therapy of
patients with leukemia.
Other studies have shown that chrysin participates
in the intrinsic pathway of apoptosis in human col-
orectal cancer cells HCT116, human liver cancer cell
line HepG2, and human nasopharyngeal carcinoma
cells CNE-1 [57]. The percentage of apoptotic
HCT116, HepG2 and CNE-1 cells increased mark-
edly after treatment with 1 ng/ml TNFa together with
10, 20 and 40 μM of chrysin. Chrysin significantly sen-
sitizes TNF-a-induced apoptosis via a caspase cas-
cade — activation of caspase-8 and caspase-3. Pre-
treatment of HCT116 cells with 40 μM chrysin and
1 ng/ml TNFa compared to the TNFa only group
(p < 0.01) inhibits IkB kinase activity, NF-kB transcrip-
tional activity and suppresses anti-apoptotic gene
c-FLIP. The above cited study indicates that chrysin as-
sociated with TNFa in its inhibitory effect on NF-kB
activation reduces c-FLIP expression in HCT116 cells.
This study advances our understanding of the mo-
lecular mechanism involved in the anti-cancer activi-
ty of chrysin.
Chrysin induces apoptosis in cancer cells by acti-
vation of caspases, suppression of anti-apoptotic pro-
teins such as IAP, c-FLIP, PI3K/Akt signal pathway,
inhibition of IKK and NF-kB activity (Figure 3). De-
spite the results of studies presenting the proapop-
totic activity of chrysin, it has been shown that Chi-
nese propolis inhibited apoptosis in neuroblastoma
cell line SH-SY5Y, caspase-3 activity and cytochrome
c releasing into the cytosol [58]. Further studies are
necessary to understand the exact mechanism of
chrysin-induced apoptosis in cancer cells.
In summary, the induction of apoptosis in vari-
ous cancer cells by propolis extracts (EEP or
WSDP) and its extremely active compounds, such
as CAPE and chrysin, depends on the concentra-
tion of the natural products used. Propolis and the
presented compounds induce the intrinsic pathway
of apoptosis through the release of cytochrome c
from mitochondria to the cytosol, through caspase
cascade and activation of pro-apoptotic proteins:
Bax, Bad, p53, and p21.
Moreover, propolis, as well as CAPE and chrysin,
enhances extrinsic pathway of apoptosis in cancer cells
stimulated by TRIAL (TNF) or Fas receptors. CAPE,
through activating p38 MAPK, JNK, ERK kinases
confirms the involvement of the intrinsic pathway of
apoptosis in the mechanism of the anticancer activi-
ty. The suppression of anti-apoptotic proteins IAP,
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c-FLIP, Bcl-2, PI3K/Akt kinase and inhibition of NF-kB
activity by chrysin have also been presented. All these
pathways are presented in Figure 3. Although many
studies have shown the proapoptotic effects of prop-
olis, CAPE and chrysin, there are also results that
suggest their antiapoptotic action. These contradic-
tory results suggest that further studies are needed to
precisely define the mechanism of action of propolis,
CAPE and chrysin in the apoptotic pathways.
Effect of propolis and its compounds on cancer cells
proliferation
Cancer cells are characterized by uncontrolled growth
and development as a result of abnormal function of
genes responsible for cell cycle regulation controlled
by complexes of cyclins and cyclin-dependent protein
kinases which stimulate the cell to move at the next
phase of the cell cycle. The cell cycle is a process reg-
ulated also by p53 protein, which as a result of DNA
Figure 2. Targeting the apoptosis pathways in cancer cells stimulated by CAPE based on: [22, 23, 30, 39–46]. Bcl-2/Bcl-X
— B cell lymphoma 2 protein/B cell lymphoma X protein; Bax — Bcl-2 associated X protein; Bak — Bcl-2 homologous
antagonist/killer protein; Cyt. C — Cytochrome C; Apaf-1 — apoptotic protease activating factor; IAP — inhibitor of
apoptosis proteins, Fas — Fas ‘fatty acid synthase’ associated protein, FasL — Fas associated protein ligand; FADD — Fas
protein associated with death domain; Daxx — death domain associated protein; TNF — tumor necrosis factor; TRAIL
— TNF related apoptosis-inducing ligand; TRADD — TNFR associated death domain protein; TRAF — TNF receptor-
associated factor-2; NF-kB — nuclear factor-kappaB; IKK — kappa B kinase; IkB — inhibitor of nuclear factor kappaB;
MAPK/p38 — mitogen-associated protein kinase and p38 pathways; JNK/p38 — c-Jun N-terminal kinase and p38
pathways; Ask-1 — apoptosis signal-regulating kinase 1; PARP — poly(ADP-ribose) polymerase; Mcl-1 — myeloid
leukemia cell differentiation protein; p21, p38, p53 — 21, 38, 53 protein
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damage increases the levels of cyclin-dependent ki-
nase (Cdk) inhibitors such as p16, p21 and p27 pro-
teins [59–61]. There are suggestions that the genes
responsible for the synthesis of cyclins are potential
oncogenes, as their deregulation or excessive expres-
sion leads to continuous Cdk activity which phospho-
rylates Rb protein [62]. The process of cancer cell
proliferation was studied after the administration of
propolis and its compounds.
Effect of propolis on cancer cells proliferation
The antiproliferative activity of propolis on U937 cells
was observed by Motomura et al. [33]. Methanol ex-
tract of propolis used at a concentration of 100–1,000
μg/ml significantly inhibited the growth of U937 cells
in a dose-dependent manner. Flow cytometric analy-
sis indicated an increase to 32.8% and 37.7% in the
number of U937 cells at the G2/M phase, for 300 μg/ml
and 500 μg/ml of propolis, respectively, as a result of
down-regulation of cyclin A, cyclin B, CDK2 expres-
sion and increasing the level of p21 and p27 proteins.
Blocking cell cycle progression at the G2 phase is
important, because the cell does not go to the next M
phase in which cancer cell division occurs.
It is believed that cancer cells are immortal be-
cause their telomeres are not curtailed due to exces-
sive telomerase activity. This allows tumor cells to avoid
aging, which protects normal cells against malignant
transformation and is considered to be a mechanism
second in importance only to apoptosis [63]. EEP (0.03
g/mL) decreased the telomerase expression to 60–93%
by suppression of the human telomerase reverse tran-
scriptase (hTERT) activity in T-cell acute lymphoblas-
tic leukemia CCFR-CEM cell line [64].
The studies discussed above show the antiprolif-
erative effects of propolis on cancer cells as a result
of DNA damage. Propolis inhibits the cell cycle by
suppression of cyclin A, cyclin B, Cdk2 expression,
increasing the level of p21, p27 proteins and inhibi-
tion of hTERT effect in tumor cells. Propolis can sup-
press cancer cell proliferation via two mechanisms:
stopping proliferation at the G2 phase, and decreas-
Figure 3. Targeting the apoptosis pathways in cancer cells stimulated by chrysin based on: [50–52]. Cyt. C — Cytochrome
C; Apaf-1 — apoptotic protease activating factor; IAP — inhibitor of apoptosis proteins; TNF — tumor necrosis factor;
TRADD — TNFR associated death domain protein; TRAF-2 — TNF receptor-associated factor-2; NF-kB — nuclear
factor-kappa B; IKK — kappa B kinase; IkB — inhibitor of nuclear factor kappa B; PARP — poly(ADP-ribose) polyme-
rase; PI3K — phosphoinositide 3-kinase; Akt — altered PI3 kinase; PLC-1g — phospholipase c-1g; cIAP — cellular
inhibitor apoptosis protein; cFLIP — cellular Flice inhibitory protein
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ing telomerase activity. Both pathways are presented
in Figure 4.
Effect of propolis compounds on cancer cells
proliferation
The wingless-type glycoprotein (WNT) signaling path-
way is involved in 90% of all colorectal cancer cases
[65]. The adenomatous polyposis coli gene or axin
which are WNT pathway suppressors, and the b-cate-
nin oncogene are strongly connected with carcinogen-
esis [66]. Mutations in the b-catenin gene were dis-
covered in colorectal, ovarian, pancreatic and pros-
tate cancer [67]. Therefore, the phosphorylation of
b-catenin by glycogen synthase kinase 3b or casein
kinase 1a is required for proteasomal degradation of
b-catenin and leads to cancer cell growth arrest. All
the WNT signals have been studied after administra-
tion of CAPE in HCT116 cell line [68].
Flow cytometry and Western blotting assay indi-
cated an increase in the number of HCT116 cells at
G0/G1 phase and a decrease in the number of S phase
cells by CAPE (2.5–10 mg/L) in a dose- and time-
Figure 4. Effect of propolis on cancer cells cycle based on: [28]. G1 phase (Gap1) — cell increase; S phase (synthesis)
— DNA replication; G2 phase (Gap2) — cell growth; M phase (mitosis) — cell division; G0 phase (Gap0) — end of cell
division; CDK — cyclin-dependent kinase; p21, p27 — 21, 27 protein
-dependent manner. Wang et al. [68] suggested that
the obtained results are due to the induction of sup-
pression of b-catenin level in cytosol and nucleus. Si-
milar results were achieved in a study by He et al. [69].
CAPE (2.5–80 mg/L) inhibited the proliferation of
SW480 colorectal cancer cells by the reduction of
b-catenin expression and suppression of cyclin D1 and
c-myc protein expression. Also, it was found that
CAPE inhibited the SW480 and HCT116 cell growth
and induced cell cycle arrest at the G1 phase in a dose-
and time-dependent manner. The obtained results
were caused by the reduction of b-catenin expression
in nucleus and cytoplasm, and downregulation of cy-
clin D1 and c-myc protein expression [70]. The above
data strongly confirms that the antiproliferative ef-
fect of CAPE on colorectal cancer cells is associated
with a decrease in b-catenin expression in cells. The
described activities of CAPE in b-catenin signaling
pathway are presented in Figure 5.
In order to better define the mechanism of CAPE
activity in cell arrest during proliferation, a study was
conducted on C6 glioma cells. CAPE (10–100 μM)
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caused a significant reduction in the number of C6
glioma cells compared to a control group (p < 0.05)
[71]. Flow cytometric assay showed an increase in the
percentage of the cells at G1 phase to 85%, and
a decrease to 7–8% at S phase. Moreover, CAPE
(50 μM) decreased CDK2/cyclin E and CDK4/cyclin D
activity and the protein level of hyperphosphorylated
pRb correlating with an increase of p21, p27, p16
expression in C6 glioma cells. This study [71] suggests
that CAPE increases cell cycle arrest at the G0/G1
phase as a result of an inhibition of pRb phosphory-
lation (Figure 6).
In summary, the studies presented above identi-
fied that CAPE inhibits colorectal cancer cells prolif-
eration and induces cell cycle arrest by downregula-
tion of b-catenin protein expression and activation of
the cyclin-dependent kinase inhibitors which prevent
pRb phosphorylation.
The effect of chrysin on proliferation was studied
in rat C6 glioma cells [72]. The proliferation and
growth of C6 cells exposed to 10–50 μM chrysin for
72 h decreased by about 30–90% (p < 0.001). Addi-
tionally, chrysin at 30–50 μM concentration increased
the number of C6 glioma cells at the G1 phase from
69% to 83% (p < 0.001), while the number of cells at
the S phase decreased from 11.4 % to 2.8%
(p < 0.001). Chrysin at 50 μM concentration reduced
the activity of CDK2/cyclin E to 8.9% (p < 0.001)
and CDK4/cyclin D to 5.7% as a result of significant
overactivity of cyclin-dependent kinase inhibitor p21
in the C6 glioma cells, but the specific inhibitor
(SB203580) of p38 MAPK downregulated the p21
protein expression and increased the C6 glioma cells
proliferation. This study suggests that chrysin increas-
es the p21 protein level by induction of the p38 MAPK
kinase activity resulting in C6 glioma cell prolifera-
tion arrest (Figure 7).
The studies presented above indicate that a mech-
anism of tumor cell cycle arrest is observed after the
administration of propolis, CAPE or chrysin. Propo-
lis and the presented compounds induce the inhibi-
tion of cell proliferation through suppression of com-
plexes of cyclins and cyclin-dependent protein kinas-
es, and increase the level of protein inhibitors such as
p21 and p27 in tumor cells.
Additionally, propolis shows an antitumor effect
as a result of inhibition of the hTERT effect in U937
cells. Moreover, it has been suggested that the anti-
proliferative effect of CAPE is associated with the
downregulation of the b-catenin expression in SW480
Figure 5. Effect of CAPE on b-catenin signaling pathway
based on: [61–65]. Fzd — frizzled receptor; Dvl — dishe-
velled family proteins; APC — Adenomatous Polyposis
Coli (APC) gene; GSK-3b — Glycogen Synthase Kinase 3b;
CKIa — Casein Kinase 1a; G1 phase (Gap1) — cell
increase
Figure 6. Effect of CAPE on process of transcription in
cancer cell based on: [66]. G1 phase (Gap1) — cell
increase; S phase (synthesis) — DNA replication; G2 phase
(Gap2) — cell growth; M phase (mitosis) — cell division;
G0 phase (Gap0) — end of cell division; CDK — cyclin-
-dependent kinase; E2F — transcription factor 2; Rb —
retinoblastoma protein; p16, p21, p27 — 16, 21, 27 protein
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and HCT116 colorectal cancer cells. Based on the
presented results, propolis inhibits cell proliferation
due to the influence at the G2 phase. CAPE and
chrysin are involved at the G0/G1 phase of cell pro-
liferation. It is possible that the effect of propolis on
cell proliferation is not only done by CAPE or chrysin.
In vivo studies
The results of the in vitro studies presented above
suggest that propolis, CAPE and chrysin have cyto-
toxic properties against cancer cells through the in-
duction of apoptosis or cell division and cell growth
arrest. Nevertheless, in vitro studies do not always
reflect the behavior of the tested product in the body.
Therefore, studies in a living organism are an im-
portant element of the research of chemotherapeu-
tic agents.
The results of an in vivo study presented by Bor-
relli et al. [73] showed the efficacy of CAPE in lim-
iting tumor growth in a rat model of colon cancer.
Azoxymethane (AOM) administered intraperito-
neally induced formation of aberrant crypt foci
(ACF) and tumors in the rat colon. CAPE adminis-
tered intraperitoneally at a dose of 50 mg/kg sig-
nificantly (p < 0.01) reduced the effects of AOM,
thus avoiding the development of ACF and tumors
in the colon. It is important to note that propolis with-
out CAPE gives no positive effect. These results may
suggest that the potential antitumor effect of propo-
lis is dependent on the presence of CAPE.
Another experiment demonstrated that propolis
administered at a dose of 160 mg/kg to mice with
Ehrlich ascitis carcinoma (EAC) cell line increased
the survival rate of the animals to 30% [74]. Propolis
significantly reduced the tumor viability and volume.
Flow cytometric analysis showed that propolis used
22 h before inoculation of EAC led to reduction of
the number of tumor cells at the S phase cell cycle,
thus arresting the tumor cells proliferation.
CAPE has an inhibitory effect on the growth of
C6 glioma cells in BALB/c-nu mice [71]. Its adminis-
tration at doses of 1 mg/kg, 5 mg/kg and 10 mg/kg to
mice after tumor inoculation caused a marked reduc-
tion of tumor volume to 39.7%, 63.4% and 78%, re-
spectively, compared to control animals. Histologi-
cal analysis presented a decrease in the number of
mitosis positive C6 glioma cells after application of
Figure 7. Influence of chrysin on cell cycle based on: [67]. G1 phase (Gap1) — cell increase; S phase (synthesis) — DNA
replication; G2 phase (Gap2) — cell growth; M phase (mitosis) — cell division; G0 phase (Gap0) — end of cell division;
p38MAPK — mitogen-activated protein kinase and p38 pathway; CDK — cyclin-dependent kinase; E2F — transcription
factor 2; Rb — retinoblastoma protein; p21 — 21 protein
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CAPE, while cells in the control group showed a com-
plete proliferation.
In vivo studies confirm the in vitro observations.
Both studies show significantly beneficial effects of
propolis, CAPE and chrysin in stopping cancer pro-
gression.
Conclusions
With an increasing incidence rate of cancer world-
wide, new anticancer agents are still required. One of
the benefits of anticancer therapy is the ability to ini-
tiate apoptosis and cell cycle arrest in cancer cells.
The studies presented in this review suggest that pro-
polis and its compounds, CAPE and chrysin, may in-
hibit cell cycle proliferation or induce apoptosis in
tumor cells. They induce the apoptotic process by
activation of Bax, p53, p21 proteins, p38 MAPK, JNK,
ERK kinases, release of cytochrome c into the cyto-
sol, and activation of caspase cascade. These effects
are not dependent on the type of tumor cell. The re-
sults of the studies cited in this review also suggest
the inhibition of NF-kB activation, the suppression
of antiapoptotic proteins, such as IAP, c-FLIP, Akt
kinase, and the initiation of extrinsic pathway of apo-
ptosis by induction of TRAIL and Fas receptor stim-
ulation in cancer cells.
Propolis and its compounds described above in-
duce the inhibition of cell proliferation by the sup-
pression of complexes of cyclins and cyclin-dependent
protein kinases, as well as by increasing the level of
protein inhibitors such as p21, p16 and p27 in tumor
cells, and inducing cell cycle arrest by decreasing
b-catenin protein expression. Although many studies
have shown the inhibitory effects of propolis and its
compounds on growth and cancer cell proliferation,
further research is necessary to understand the effi-
ciency and mechanism of their beneficial effects.
Propolis, as a component of many active substanc-
es, possesses anticancer properties. The beneficial
antiproliferative and antiapoptotic activities of CAPE
and chrysin are not always based on similar mecha-
nisms as propolis. Propolis and its compounds could
be potentially useful as chemotherapeutic or chemo-
preventive anticancer drugs.
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